Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants
Description
The global COVID-19 pandemic arising from SARS-CoV-2 has impacted many lives, gaining interest worldwide ever since it was first identified in December 2019. Till 2023, 752 million cumulative cases and 6.8 million deaths were documented globally